Medartis Holding AG

SWX:MED 주식 보고서

시가총액: CHF 793.1m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Medartis Holding 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Christoph Bronnimann

최고 경영자

CHF 1.9m

총 보상

CEO 급여 비율26.8%
CEO 임기5yrs
CEO 소유권0.3%
경영진 평균 재임 기간3.7yrs
이사회 평균 재임 기간3.4yrs

최근 관리 업데이트

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Recent updates

The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Aug 27
The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business

Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

Aug 21
Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares

When Should You Buy Medartis Holding AG (VTX:MED)?

May 10
When Should You Buy Medartis Holding AG (VTX:MED)?

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Feb 14
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Oct 24
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Is Medartis Holding (VTX:MED) A Risky Investment?

Oct 03
Is Medartis Holding (VTX:MED) A Risky Investment?

Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 06
Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Jun 21
Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Jan 31
Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

Oct 30
Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

Sep 07
These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

When Should You Buy Medartis Holding AG (VTX:MED)?

Jul 29
When Should You Buy Medartis Holding AG (VTX:MED)?

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

May 06
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Feb 08
At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Jan 18
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Nov 10
We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Sep 29
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

Jun 08
Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

Mar 16
How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

We're Watching These Trends At Medartis Holding (VTX:MED)

Feb 09
We're Watching These Trends At Medartis Holding (VTX:MED)

Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

Jan 04
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Nov 19
What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

CEO 보상 분석

Christoph Bronnimann 의 보수는 Medartis Holding 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

CHF 4m

Mar 31 2024n/an/a

CHF 2m

Dec 31 2023CHF 2mCHF 500k

CHF 619k

Sep 30 2023n/an/a

-CHF 3m

Jun 30 2023n/an/a

-CHF 7m

Mar 31 2023n/an/a

-CHF 6m

Dec 31 2022CHF 2mCHF 500k

-CHF 6m

Sep 30 2022n/an/a

-CHF 3m

Jun 30 2022n/an/a

-CHF 241k

Mar 31 2022n/an/a

CHF 3m

Dec 31 2021CHF 3mCHF 500k

CHF 7m

Sep 30 2021n/an/a

CHF 9m

Jun 30 2021n/an/a

CHF 12m

Mar 31 2021n/an/a

CHF 6m

Dec 31 2020CHF 2mCHF 467k

-CHF 944k

Sep 30 2020n/an/a

-CHF 3m

Jun 30 2020n/an/a

-CHF 4m

Mar 31 2020n/an/a

-CHF 1m

Dec 31 2019CHF 782kCHF 168k

CHF 2m

보상 대 시장: Christoph 의 총 보상 ($USD 2.11M )은 Swiss 시장( $USD 1.46M ).

보상과 수익: Christoph 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Christoph Bronnimann (58 yo)

5yrs

테뉴어

CHF 1,866,937

보상

Dr. Christoph Bronnimann is Chief Executive Officer at Medartis AG since September 2019. He has been the Chief Executive Officer and Member of Executive Management Board at Medartis Holding AG since Septem...


리더십 팀

이름위치테뉴어보상소유권
Christoph Bronnimann
CEO & Member of Executive Management Board5yrsCHF 1.87m0.27%
CHF 2.1m
Thomas Straumann
Founder & Vice Chairman26.7yrsCHF 291.97k41.41%
CHF 328.5m
Dirk Kirsten
CFO & Member of the Executive Management Board3.5yrs데이터 없음0.029%
CHF 231.9k
Mareike Loch
VP of EMEA & Member of Executive Management Board4.1yrs데이터 없음0.053%
CHF 424.2k
Manuel Schaer
CTO & Member of the Executive Board3.8yrs데이터 없음0.017%
CHF 134.8k
Mario Casa
COO & Member of Management Board2.7yrs데이터 없음0.0027%
CHF 21.3k
Inge Maes
Chief Human Resources Officer & Executive Management Board Memberno data데이터 없음데이터 없음
Anisha Wharton
Head of Regulatory Affairs3.5yrs데이터 없음데이터 없음

3.7yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: MED 의 관리팀은 경험 ( 3.4 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Thomas Straumann
Founder & Vice Chairman26.7yrsCHF 291.97k41.41%
CHF 328.5m
Damien Tappy
Independent Non-Executive Director6.7yrsCHF 188.29k0.19%
CHF 1.5m
Marco Gadola
Independent Chairman4.4yrsCHF 568.06k0.065%
CHF 516.3k
Ciro Roemer
Independent Director2.4yrsCHF 112.76k0.0096%
CHF 76.5k
Willi Miesch
Independent Non Executive Director14.7yrsCHF 161.68k4.55%
CHF 36.1m
Martha Shadan
Independent Non-Executive Directorless than a year데이터 없음데이터 없음
Jennifer Dean
Independent Non-Executive Directorless than a year데이터 없음데이터 없음
Nadia Schmidt
Independent Director2.4yrsCHF 171.53k0.0072%
CHF 57.3k

3.4yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: MED 의 이사회경험(평균 재직 기간 3.2 년)으로 간주됩니다.